Ventavis

Ventavis

iloprost

Manufacturer:

Bayer HealthCare Pharma

Distributor:

DKSH
Concise Prescribing Info
Contents
Iloprost
Indications/Uses
Primary or secondary pulmonary HTN due to connective tissue disease or drug induction, in moderate or severe stages of the disease. Moderate or severe secondary pulmonary HTN due to chronic pulmonary thromboembolism where surgery is not possible.
Dosage/Direction for Use
6-9 inhalations/day each lasting about 5-10 min.
Contraindications
Risk of hemorrhage (eg, active peptic ulcers, injuries), suspected pulmonary congestion, blocked or narrow vein, stroke w/in last 3 mth; heart problems eg, heart attack w/in last 6 mth, severe arrhythmias, angina, CHD, untreated heart disease, valvular defects. Pregnancy, lactation, childn <18 yr.
Special Precautions
Pulmonary infections, severe asthma, low systemic BP (<85 mmHg). Severe renal & hepatic failure. May impair the ability to drive or operate machinery.
Adverse Reactions
Flushing, increased coughing, hypotension, headache, jaw spasm, hemorrhage.
Drug Interactions
Antihypertensives, anticoagulants, corticosteroids.
ATC Classification
B01AC11 - iloprost ; Belongs to the class of platelet aggregation inhibitors excluding heparin. Used in the treatment of thrombosis.
Presentation/Packing
Form
Ventavis inhalation soln 10 mcg/mL
Packing/Price
2 mL x 30 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in